We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Defeat Leaves Molecular Scar in Brain

By Biotechdaily staff writers
Posted on 15 Mar 2006
Researchers studying a mouse model of depression found that repeated defeat by dominant animals leaves a mouse with an enduring molecular scar in its brain, which may help to explain why depression is so difficult to cure.

In the mouse model, silencer molecules turned off a gene for a key protein in the brain's hippocampus. More...
After activating a compensatory mechanism, an antidepressant was able to temporarily restore the animal's sociability and the protein's expression but failed to remove the silencers. A true cure for depression would probably have to target this scar, according to the researchers, from the University of Texas Southwestern Medical Center (Dallas, TX, USA). Their findings were reported in the February 26, 2006, online edition of Nature Neuroscience.

Mice exposed to aggression by a different dominant mouse daily for 10 days became socially defeated and strongly avoided other mice, even weeks later. The expression of a representative gene in the hippocampus, a memory center implicated in depression, fell three-fold and remained suppressed for weeks. Chronic treatment with imipramine, a tricyclic antidepressant, restored expression of the gene for brain-derived neurotrophic factor (BDNF) to normal levels and reversed social withdrawal behavior.

The researchers traced the gene expression changes to long-lasting modifications in histones, which are proteins that regulate the turning on-and-off of genes via methylation. The drug imipramine was unable to remove these silencer molecules, suggesting that they remained as a latent source of vulnerability to future stress.

"The molecular scar induced by chronic stress in the hippocampus, and perhaps elsewhere in the brain, can't easily be reversed,” noted lead researcher Eric Nestler, M.D., of the Southwestern Medical Center. "To really cure depression, we probably need to find new treatments that can remove the silencer molecules.”



Related Links:
U. Texas Southwestern Medical Center

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.